165 related articles for article (PubMed ID: 35436275)
21. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.
Vergori A; Pianura E; Lorenzini P; D'Abramo A; Di Stefano F; Grisetti S; Vita S; Pinnetti C; Donno DR; Marini MC; Nicastri E; Ianniello S; Antinori A;
Ann Med; 2021 Dec; 53(1):295-301. PubMed ID: 33491498
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
23. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study.
Scarduelli C; Inglese F; Beccaria M; Spreafico F; Garuti M; Pecoriello A; Cervi G; Greco G; Scarduelli S; Lucchini G; De Donno G; Borghi C
Monaldi Arch Chest Dis; 2021 Mar; 91(3):. PubMed ID: 33728885
[TBL] [Abstract][Full Text] [Related]
25. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlundh U; Nicolas S; Nilsson P; Nylander G
N Engl J Med; 1996 Sep; 335(10):696-700. PubMed ID: 8703168
[TBL] [Abstract][Full Text] [Related]
26. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
Weiss A; Brose S; Ploetze K; Matschke K
Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
[TBL] [Abstract][Full Text] [Related]
27. A retroperitoneal bleed induced by enoxaparin therapy.
Ernits M; Mohan PS; Fares LG; Hardy H
Am Surg; 2005 May; 71(5):430-3. PubMed ID: 15986976
[TBL] [Abstract][Full Text] [Related]
28. Postoperative Deep Vein Thrombosis, Pulmonary Embolism, and Myocardial Infarction: Complications After Therapeutic Anticoagulation in the Patient With Spine Trauma.
Shiu B; Le E; Jazini E; Weir TB; Costales T; Caffes N; Paryavi E; O'Hara N; Gelb DE; Koh EY; Ludwig SC
Spine (Phila Pa 1976); 2018 Jul; 43(13):E766-E772. PubMed ID: 29215498
[TBL] [Abstract][Full Text] [Related]
29. Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis.
Cimminiello C; Prandoni P; Agnelli G; Di Minno G; Polo Friz H; Scaglione F; Boracchi P; Marano G; Harenberg J
Intern Emerg Med; 2017 Dec; 12(8):1291-1305. PubMed ID: 28756546
[TBL] [Abstract][Full Text] [Related]
30. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
31. Enoxaparin-induced spontaneous massive retroperitoneal hematoma with fatal outcome.
Salemis NS; Oikonomakis I; Lagoudianakis E; Boubousis G; Tsakalakis C; Sourlas S; Gourgiotis S
Am J Emerg Med; 2014 Dec; 32(12):1559.e1-3. PubMed ID: 24972961
[TBL] [Abstract][Full Text] [Related]
32. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
33. [Prospective randomized study comparing the effectiveness and tolerance of various low-molecular-weight heparins in high risk patients].
Janni W; Bergauer F; Rjosk D; Lohscheidt K; Hagena FW
Zentralbl Chir; 2001 Jan; 126(1):32-8. PubMed ID: 11227291
[TBL] [Abstract][Full Text] [Related]
34. [Low-molecular-weight heparin for the treatment of acute pulmonary thromboembolism. Comparison with unfractionated intravenous heparin].
Alonso Martínez JL; Abínzano Guillén ML; Solano Remírez M; Alvarez Frías MT; Gutiérrez Dubois J; Munuera García L
An Med Interna; 2005 Apr; 22(4):177-81. PubMed ID: 16004514
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.
Lim W; Dentali F; Eikelboom JW; Crowther MA
Ann Intern Med; 2006 May; 144(9):673-84. PubMed ID: 16670137
[TBL] [Abstract][Full Text] [Related]
36. [Learning with COVID-19: what about anticoagulation?].
Álvarez-Rodríguez E; González González R; Torres-Gárate R; López-Riquelme P; González Martil I; Abad Cuñado V
An Sist Sanit Navar; 2020 Aug; 43(2):251-254. PubMed ID: 32865189
[TBL] [Abstract][Full Text] [Related]
37. Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel.
Cherfan A; Arabi Y; Al Askar A; Al Shimemeri A
Pharmacotherapy; 2007 May; 27(5):755-9. PubMed ID: 17461711
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
[TBL] [Abstract][Full Text] [Related]
39. [Massive retroperitoneal hematoma during enoxaparin combined with aspirin treatment of acute pulmonary embolism: a case report].
Zhang H; Wu WD
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):468-9. PubMed ID: 19100051
[No Abstract] [Full Text] [Related]
40. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
